Which cholesterol type is commonly targeted for reduction to lower heart disease risk?

Which cholesterol type is commonly targeted for reduction to lower heart disease risk?

• A. HDL
• B. Chylomicrons
• C. VLDL
• D. LDL

Answer: (D)

LDL cholesterol is typically targeted for reduction because it directly drives the formation of atherosclerotic plaques in arteries. When LDL carries cholesterol into arterial walls, it can become trapped, oxidize, and trigger inflammatory processes that lead to plaque buildup. This plaque narrows arteries and can rupture, causing heart attacks or strokes. Lowering LDL-C with therapies like statins, lifestyle changes, or other medications reduces the amount of cholesterol reaching the arteries and lowers the risk of cardiovascular events, which is why it’s the primary focus in managing heart disease risk. HDL, while often called “good” cholesterol, assists in removing cholesterol from arteries, and simply raising HDL has not consistently reduced risk on its own. Chylomicrons and VLDL carry triglycerides and are more about triglyceride transport and metabolic state; they’re not the main targets for lowering heart disease risk in the way LDL is.

LDL cholesterol is typically targeted for reduction because it directly drives the formation of atherosclerotic plaques in arteries. When LDL carries cholesterol into arterial walls, it can become trapped, oxidize, and trigger inflammatory processes that lead to plaque buildup. This plaque narrows arteries and can rupture, causing heart attacks or strokes. Lowering LDL-C with therapies like statins, lifestyle changes, or other medications reduces the amount of cholesterol reaching the arteries and lowers the risk of cardiovascular events, which is why it’s the primary focus in managing heart disease risk.

HDL, while often called “good” cholesterol, assists in removing cholesterol from arteries, and simply raising HDL has not consistently reduced risk on its own. Chylomicrons and VLDL carry triglycerides and are more about triglyceride transport and metabolic state; they’re not the main targets for lowering heart disease risk in the way LDL is.